Leaflet GELISIA 1mg/g 1mg / ml single dose ophthalmic gel


Indicated for: glaucoma; hypertension

Route of administration: ophthalmic

Substance: timolol (beta blocker)

ATC: S01ED01 (Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents)

Timolol is a beta-blocker primarily used for the treatment of glaucoma and ocular hypertension. It reduces intraocular pressure by decreasing the production of aqueous humor in the eye, thereby preventing optic nerve damage.

The medication is available as eye drops and should be administered as directed by a doctor. Typically, one drop is applied to the affected eye once or twice daily.

Patients should be aware of potential side effects, such as eye irritation, dryness, or blurred vision. It is important to inform the doctor of any unusual symptoms or the use of other medications.

Common side effects include eye irritation, a burning or stinging sensation upon application, and dryness. In rare cases, systemic reactions such as bradycardia or breathing difficulties may occur. Patients should be informed of these risks before starting treatment.

General data about GELISIA 1mg/g 1mg / ml

  • Substance: timolol
  • Date of last drug list: 01-07-2023
  • Commercial code: W69603001
  • Concentration: 1mg / ml
  • Pharmaceutical form: single dose ophthalmic gel
  • Quantity: 10
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: SIFI S.P.A. - ITALIA
  • Holder: SIFI S.P.A. - ITALIA
  • Number: 15033/2023/01
  • Shelf life: 2 years-after packing for marketing;after the first opening a recipientului-se utilizeaza imedia

Concentrations available for timolol

  • 0.25%
  • 0.5%
  • 1mg/g
  • 1mg/ml
  • 2.5mg/ml
  • 5mg/ml